Novo Nordisk receives EU committee recommendation for oral Wegovy pill

Go back to Novo Nordisk receives EU committee recommendation for oral Wegovy pill
NOVO-NORDISK A/S (NYSE: NVO) Delayed: 47.42 +1.54 (3.36%)
Previous Close $45.88    52 Week High $59.00 
Open $46.80    52 Week Low $32.80 
Day High $47.43    P/E N/A 
Day Low $46.44    EPS $0.00 
Volume 20,200,245